Attached files

file filename
EX-99.1 - EX-99.1 - Oncternal Therapeutics, Inc.d305435dex991.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): February 21, 2012

 

 

 

GTx, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   000-50549   62-1715807

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

175 Toyota Plaza

7th Floor

Memphis, Tennessee 38103

(901) 523-9700

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code:         

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


ITEM 2.02 Results of Operations and Financial Condition.

On February 21, 2012, GTx, Inc. issued an earnings release for the fourth quarter and year ended December 31, 2011, a copy of which is furnished as Exhibit 99.1 to this Current Report.

This release is furnished by GTx pursuant to Item 2.02 of Form 8-K and is not to be considered “filed” under the Exchange Act, and shall not be incorporated by reference into any previous or future filing by the Registrant under the Securities Act or the Exchange Act.

ITEM 9.01 Financial Statements and Exhibits.

(c) Exhibits

 

Exhibit

Number

  

Description

99.1    Press Release issued by GTx, Inc. dated February 21, 2012


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    GTx, INC.
Date: February 21, 2012     By:   /s/ Mark E. Mosteller
    Name:   Mark E. Mosteller
    Title:  

Vice President and Chief Financial Officer

(principal accounting and financial officer)